Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: Changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor-Reference-Cited by-同舟云学术

Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: Changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor

Published:1995-03 Issue:3 Volume:98 Page:257-265
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Kohno Masakazu,Horio Takeshi,Yokokawa Koji,Yasunari Kenichi,Ikeda Miwako,Minami Mieko,Kurihara Naotsugu,Takeda Tadanao

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. A new natriuretic peptide in porcine brain;Sudoh;Nature,1988

2. The presence of brain natriuretic peptide of 12,000 daltons in porcine heart;Minamino;Biochem Biophys Res Commun.,1988

3. Isolation and sequence determination of human brain natriuretic peptide in human atrium;Kambayashi;FEBS Lett.,1990

4. Human brain natriuretic peptide, a novel cardiac hormone;Mukoyama;Lancet,1990

5. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide;Mukoyama;J Clin Invest.,1990

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DIAGNOSTIC EFFİCACY OF NATRIURETIC PEPTIDE: NT-proBNP IN HEMODIALYSIS PATIENTS WITH LEFT VENTRICULAR FAILURE;SDÜ Tıp Fakültesi Dergisi;2024-06-03

2. Serum-Induced Expression of Brain Natriuretic Peptide Contributes to Its Increase in Patients with HFpEF;International Journal of Molecular Sciences;2022-03-10

3. The Mechanism Actions of Astragaloside IV Prevents the Progression of Hypertensive Heart Disease Based on Network Pharmacology and Experimental Pharmacology;Frontiers in Pharmacology;2021-11-05

4. Cardiac congestion assessed by natriuretic peptides oversimplifies the definition and treatment of heart failure;ESC Heart Failure;2021-07-13

5. Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry;European Heart Journal;2019-12-28